drugset / Trial / NCT00835822

Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency

NCT00835822 ↗

Phase 4 Completed 216 enrolled Abbott Statistika Consultoria Ltda · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the therapeutic efficacy and safety of Venocur Triplex®, administered BID for 60 days in patients with Chronic Venous Insufficiency rated between CEAP 2 and 4, in comparison to a Placebo group.

Timeline

Start
2005-05
Primary completion
2006-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Venocur Triplex® Unknown — Oral

Indications